Why Boeing Stock Just Popped

Boeing shares rose 3.4% following reports that the company expects certification of its 737 MAX 7 and MAX 10 models by year-end, representing potential fulfillment of 1,532 orders. Additionally, Boeing plans to increase 737 MAX production from 38 to 42 planes per month, and then to 47 by early 2026, potentially boosting annual revenue by 24%; however, the article suggests the stock remains a sell.

Analysis

Boeing's stock (NYSE: BA) increased by 3.4% following reports of significant operational developments. The company anticipates completing certification for its 737 MAX 7 and 737 MAX 10 models by the end of the year, addressing a backlog of 1,200 MAX 10 and 332 MAX 7 orders, which represent tens of billions of dollars at list prices. Concurrently, Boeing plans to ramp up 737 MAX production from the current 38 aircraft per month to 42 later this year, and further to 47 per month by early 2026. This planned approximate 24% increase in 737 production is projected to yield a corresponding boost to revenue and cash flow for Boeing's most popular product line. Such an increase could elevate Boeing's estimated $66.5 billion annual revenue for 2024 to around $82 billion, a figure comparable to its 2012 sales when earnings stood at $3.9 billion. While there was also positive news regarding a potential lift on certain tariffs, the primary drivers for the stock movement were these company-specific announcements. However, even if Boeing successfully executes this production ramp-up and achieves 2012-level earnings, the resultant price-to-earnings ratio would be approximately 39 times, a level considered high, particularly given the inherent uncertainty in achieving these production targets, leading the source article to maintain a 'sell' opinion on the stock.

Key Decisions for Investors

• Investors should recognize the potential for substantial revenue growth stemming from the anticipated certification of the 737 MAX 7 and MAX 10 models and the planned 24% increase in 737 MAX production, which could elevate annual revenues to circa $82 billion.
• It is crucial to weigh these positive operational prospects against the significant execution risk associated with achieving the ambitious production ramp-up from 38 to 47 planes per month within the specified timeframe.
• Carefully evaluate the stock's valuation, as even a successful return to 2012-level earnings of $3.9 billion alongside the projected revenue growth would result in a price-to-earnings ratio of approximately 39, a figure the source article deems too high, underpinning its 'sell' recommendation.